BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 28702565)

  • 1. Identifying the common genetic networks of ADR (adverse drug reaction) clusters and developing an ADR classification model.
    Hwang Y; Oh M; Jang G; Lee T; Park C; Ahn J; Yoon Y
    Mol Biosyst; 2017 Aug; 13(9):1788-1796. PubMed ID: 28702565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Large-scale identification of adverse drug reaction-related proteins through a random walk model.
    Chen X; Shi H; Yang F; Yang L; Lv Y; Wang S; Dai E; Sun D; Jiang W
    Sci Rep; 2016 Nov; 6():36325. PubMed ID: 27805066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid Assessment of Adverse Drug Reactions by Statistical Solution of Gene Association Network.
    Xiang YP; Liu K; Cheng XY; Cheng C; Gong F; Pan JB; Ji ZL
    IEEE/ACM Trans Comput Biol Bioinform; 2015; 12(4):844-50. PubMed ID: 26357325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying the causative proteins of similar side effect pairs to explore the common molecular basis of these side effects.
    Wang Y; Chen X; Liu L; Chen Y; Ma H; Yang R; Liu X
    Mol Biosyst; 2015 Jul; 11(7):2060-7. PubMed ID: 25992869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting adverse drug reactions of combined medication from heterogeneous pharmacologic databases.
    Zheng Y; Peng H; Zhang X; Zhao Z; Yin J; Li J
    BMC Bioinformatics; 2018 Dec; 19(Suppl 19):517. PubMed ID: 30598065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Data-driven prediction of adverse drug reactions induced by drug-drug interactions.
    Liu R; AbdulHameed MDM; Kumar K; Yu X; Wallqvist A; Reifman J
    BMC Pharmacol Toxicol; 2017 Jun; 18(1):44. PubMed ID: 28595649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting adverse drug reaction profiles by integrating protein interaction networks with drug structures.
    Huang LC; Wu X; Chen JY
    Proteomics; 2013 Jan; 13(2):313-24. PubMed ID: 23184540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Machine learning workflow to enhance predictions of Adverse Drug Reactions (ADRs) through drug-gene interactions: application to drugs for cutaneous diseases.
    Raja K; Patrick M; Elder JT; Tsoi LC
    Sci Rep; 2017 Jun; 7(1):3690. PubMed ID: 28623363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Supervised signal detection for adverse drug reactions in medication dispensing data.
    Hoang T; Liu J; Roughead E; Pratt N; Li J
    Comput Methods Programs Biomed; 2018 Jul; 161():25-38. PubMed ID: 29852965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fast Screening Technology for Drug Emergency Management: Predicting Suspicious SNPs for ADR with Information Theory-based Models.
    Liang Z; Liu J; Huang JX; Zeng X
    Comb Chem High Throughput Screen; 2018; 21(2):93-99. PubMed ID: 29336255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ontology-based literature mining and class effect analysis of adverse drug reactions associated with neuropathy-inducing drugs.
    Hur J; Özgür A; He Y
    J Biomed Semantics; 2018 Jun; 9(1):17. PubMed ID: 29880031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic analysis of the associations between adverse drug reactions and pathways.
    Chen X; Wang Y; Wang P; Lian B; Li C; Wang J; Li X; Jiang W
    Biomed Res Int; 2015; 2015():670949. PubMed ID: 26495310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Large-scale prediction of adverse drug reactions using chemical, biological, and phenotypic properties of drugs.
    Liu M; Wu Y; Chen Y; Sun J; Zhao Z; Chen XW; Matheny ME; Xu H
    J Am Med Inform Assoc; 2012 Jun; 19(e1):e28-35. PubMed ID: 22718037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mining Real-World Big Data to Characterize Adverse Drug Reaction Quantitatively: Mixed Methods Study.
    Yue QX; Ding RF; Chen WH; Wu LY; Liu K; Ji ZL
    J Med Internet Res; 2024 May; 26():e48572. PubMed ID: 38700923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of adverse drug reactions that may be related to pharmacogenetics in a public hospital in the South of Brazil.
    Camargo AC; Matte U; Botton MR
    Expert Opin Drug Saf; 2023; 22(7):621-627. PubMed ID: 36794346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring drug safety in Astrakhan, Russia.
    Kirilochev OO; Dorfman IP; Umerova AR
    Int J Risk Saf Med; 2015; 27 Suppl 1():S33-4. PubMed ID: 26639700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving drug safety: From adverse drug reaction knowledge discovery to clinical implementation.
    Tan Y; Hu Y; Liu X; Yin Z; Chen XW; Liu M
    Methods; 2016 Nov; 110():14-25. PubMed ID: 27485605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse drug reactions in Colombian patients, 2007-2013: Analysis of population databases.
    Machado-Alba JE; Londoño-Builes MJ; Echeverri-Cataño LF; Ochoa-Orozco SA
    Biomedica; 2016 Mar; 36(1):59-66. PubMed ID: 27622439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Filtering big data from social media--Building an early warning system for adverse drug reactions.
    Yang M; Kiang M; Shang W
    J Biomed Inform; 2015 Apr; 54():230-40. PubMed ID: 25688695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical association between pharmacogenomics and adverse drug reactions.
    Zhou ZW; Chen XW; Sneed KB; Yang YX; Zhang X; He ZX; Chow K; Yang T; Duan W; Zhou SF
    Drugs; 2015 Apr; 75(6):589-631. PubMed ID: 25895462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.